4 completed. 3 Phase 1, 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 3 |
| Phase 2 | 1 | Completed 1 |
| Phase 3 | 1 | Completed 1 |
Follow Cortexyme Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Single and Multiple Ascending Dose Study of COR588 COR588, Placebo - Healthy Volunteers | Phase 1 | Completed | Cortexyme Inc. | 64 | 2021-08-26 | 2022-07-20 |
| GAIN Trial: Phase 2/3 Study of COR388 in Subjects With Alzheimer's Disease COR388 capsule, Placebo capsule - Alzheimer Disease | Phase 2 / Phase 3 | Completed | Cortexyme Inc. | 643 | 2019-03-28 | 2023-02-23 |
| A Multiple Ascending Dose Study of COR388 COR388, Placebo - Alzheimer Disease | Phase 1 | Completed | Cortexyme Inc. | 33 | 2018-03-06 | 2018-11-07 |
| Study of COR388 HCl in Healthy Subjects COR388, Placebo - Healthy Subjects | Phase 1 | Completed | Cortexyme Inc. | 34 | 2017-12-11 | 2018-04-18 |
COR388 (3)
United States (3) · Australia (1) · France (1) · Netherlands (1) · Poland (1) · Spain (1) · United Kingdom (1)
Karen Smith, MD (1)